Getinge AB
STO:GETI B
Relative Value
The Relative Value of one
GETI B
stock under the Base Case scenario is
hidden
SEK.
Compared to the current market price of 189.6 SEK,
Getinge AB
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
GETI B Competitors Multiples
Getinge AB Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Getinge AB
STO:GETI B
|
51.6B SEK | 1.5 | 22.7 | 8.9 | 13.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.3B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.4B USD | 17 | 60 | 45.5 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
133.5B USD | 5.3 | 41.1 | 21 | 25.3 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.5B USD | 3.2 | 24.6 | 13.6 | 19.8 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
105.6B USD | 5.3 | 36.4 | 21.4 | 28.7 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43.5B EUR | 1.9 | 20.6 | 11.5 | 16.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.9B USD | 8.1 | 45.6 | 25.1 | 27.5 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.8B USD | 10.9 | 44.2 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
46B USD | 2.1 | 26.2 | 10.3 | 17.3 | |
| US |
|
Resmed Inc
NYSE:RMD
|
34B USD | 6.3 | 22.9 | 16.1 | 17.9 |